over 95% sp depreciation over past 4 years
constant churn of senior leaders and bod members
backtracking on gotomarket strategy costing millions for company to then go to leveraged deal with almost zero return
increasing bod salary 25% when no milestones hit
little active commitment to get skin in the game
lots of slick hockey stick presentations with inacurate forecasts which dont match reality
company alway in precarious situation regarding next CR while management continue to take big paychecks.
the list goes on.
on positive is the savr clinical trial which in reality could have been done several years ago and regulatory approved getting a nice return of all long suffering shareholders by now
I await a resignation notice for someone who can take this company to a better place.